[{"uuid": "2890a70c-1cfc-3f00-9f90-37451ca06969", "title": "Perspective Therapeutics Says Updated Interim Findings From Phase 1/2a Study Support Further Dose-Finding Research", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/perspective-therapeutics-says-updated-interim-152222235.html", "providerPublishTime": 1737732142, "type": "STORY", "relatedTickers": ["CATX"]}, {"uuid": "6a3aac2e-f4c4-36ac-aef4-1d805463076a", "title": "Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/perspective-therapeutics-touts-encouraging-updated-171841549.html", "providerPublishTime": 1737739121, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/MIM0aTDiLUxxGaI7Twi3Dw--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d08b2097d7419505935ba7982ef3f702", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/wCQoLvuBlDyw31Re82kNHg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/d08b2097d7419505935ba7982ef3f702", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "8c7ed9cb-f927-31d5-91b5-dd1e11743748", "title": "Sector Update: Health Care Stocks Advance Late Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-advance-205124866.html", "providerPublishTime": 1737751884, "type": "STORY"}, {"uuid": "d9938149-003d-39bc-9b19-c1e8ad3efba6", "title": "Sector Update: Health Care", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-202833680.html", "providerPublishTime": 1737750513, "type": "STORY", "relatedTickers": ["CATX"]}, {"uuid": "18c7959b-e412-3506-a431-ef1fa9a3048e", "title": "Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-\u03b1-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers Symposium", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/perspective-therapeutics-continues-pursue-dose-120000650.html", "providerPublishTime": 1737720000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0f4ALtDOipDFuJkz52V.lg--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 624, "height": 131, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oe761Rp76xcT4G21JP_zwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "5529e782-3779-3db7-a511-b7b1ab5c15a1", "title": "Perspective Therapeutics to Discuss Data on [212Pb]VMT-\u03b1-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/perspective-therapeutics-discuss-data-212pb-120000302.html", "providerPublishTime": 1737547200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0f4ALtDOipDFuJkz52V.lg--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 624, "height": 131, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oe761Rp76xcT4G21JP_zwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "d4cd9d44-0030-300b-a233-89fe0688cd04", "title": "Perspective Therapeutics provides business updates, strategic priorities", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/perspective-therapeutics-provides-business-updates-133535711.html", "providerPublishTime": 1736861735, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/zzQJwVxfC_2TzhvJl13Lkg--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/6e60166f16c98d232e4fe2b08fd8a093", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/hTbU71..IjOzmgi0ComIjA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/6e60166f16c98d232e4fe2b08fd8a093", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "1ec98430-76f9-3a6b-bbf0-c276e86146a9", "title": "Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/perspective-therapeutics-provides-business-updates-130000203.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0f4ALtDOipDFuJkz52V.lg--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 624, "height": 131, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oe761Rp76xcT4G21JP_zwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "aedc3593-64a4-3eb0-8202-03b5c832804b", "title": "Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/perspective-therapeutics-present-43rd-annual-120000498.html", "providerPublishTime": 1736510400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0f4ALtDOipDFuJkz52V.lg--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 624, "height": 131, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oe761Rp76xcT4G21JP_zwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "aafa87ca-0fed-307f-9379-be892580b30f", "title": "Perspective Therapeutics Appoints Juan Graham as CFO; Shares Fall", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/perspective-therapeutics-appoints-juan-graham-151858552.html", "providerPublishTime": 1736176738, "type": "STORY", "relatedTickers": ["CATX"]}, {"uuid": "346ac1f6-0e7f-3b81-8d17-6d71715a4a56", "title": "Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/perspective-therapeutics-appoints-juan-graham-130000718.html", "providerPublishTime": 1736168400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0f4ALtDOipDFuJkz52V.lg--~B/aD0xMzE7dz02MjQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 624, "height": 131, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oe761Rp76xcT4G21JP_zwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/838f217da615df0b6c09f0e2557cd05f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}, {"uuid": "00ef5c1f-fd69-3642-b7c3-cf866a4f5816", "title": "Is Perspective Therapeutics (CATX) the Best Multibagger Stock to Buy Heading into 2025?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/perspective-therapeutics-catx-best-multibagger-062659240.html", "providerPublishTime": 1731738419, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/3SPkj4MHBLtwJTakhC2Bzg--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/89f40f7fc6874992a85bf82fc1eba21d", "width": 768, "height": 430, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1FO4WRPkIY_XNCLtTfmW6Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/89f40f7fc6874992a85bf82fc1eba21d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CATX"]}]